Bolt Biotherapeutics, Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-02-04

Reporting Person: MILLER RICHARD A MD (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15602	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.73	2029-11-13	Common Stock (10808)		Direct

Footnotes

F1: 1/48th of the shares subject to the option shall vest on the one-month anniversary of July 2, 2019 (the "Vesting Commencement Date") and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider to the Issuer through each such date.